ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 131 filers reported holding ARRAY BIOPHARMA INC in Q2 2016. The put-call ratio across all filers is 2.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $13,000 | -13.3% | 285 | -53.3% | 0.01% | -12.5% |
| Q1 2019 | $15,000 | +15.4% | 610 | 0.0% | 0.01% | +14.3% |
| Q4 2018 | $13,000 | +18.2% | 610 | -15.3% | 0.01% | +16.7% |
| Q3 2018 | $11,000 | -8.3% | 720 | 0.0% | 0.01% | -14.3% |
| Q2 2018 | $12,000 | 0.0% | 720 | -2.7% | 0.01% | 0.0% |
| Q1 2018 | $12,000 | +33.3% | 740 | 0.0% | 0.01% | +40.0% |
| Q4 2017 | $9,000 | -99.9% | 740 | +27.6% | 0.01% | -37.5% |
| Q3 2017 | $13,407,000 | +47.0% | 580 | -46.8% | 0.01% | +33.3% |
| Q2 2017 | $9,123,000 | -1.4% | 1,090 | 0.0% | 0.01% | 0.0% |
| Q1 2017 | $9,254,000 | +92440.0% | 1,090 | 0.0% | 0.01% | 0.0% |
| Q4 2016 | $10,000 | +150.0% | 1,090 | 0.0% | 0.01% | +100.0% |
| Q2 2016 | $4,000 | +100.0% | 1,090 | +113.7% | 0.00% | +200.0% |
| Q1 2016 | $2,000 | – | 510 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 9,169,276 | $66,110,000 | 11.67% |
| Redmile Group, LLC | 13,623,620 | $98,226,000 | 8.05% |
| First Light Asset Management, LLC | 849,374 | $6,124,000 | 2.88% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 9,529,361 | $68,707,000 | 2.29% |
| Opus Point Partners Management, LLC | 320,000 | $2,307,000 | 1.83% |
| KOPP INVESTMENT ADVISORS LLC | 383,022 | $2,762,000 | 1.23% |
| Artal Group S.A. | 3,710,000 | $26,749,000 | 1.15% |
| EcoR1 Capital, LLC | 400,000 | $2,884,000 | 0.96% |
| Cormorant Asset Management, LP | 850,000 | $6,129,000 | 0.82% |
| SPHERA FUNDS MANAGEMENT LTD. | 800,000 | $5,768,000 | 0.56% |